Multi-sample WGS revealed the critical distinction for individuals with BE who progress to ESAD is clonal expansion of TP53 −/− cell populations and subsequent complex chromosomal structural events, which can be detected before the diagnosis of cancer and are highly specific to progression to ESAD. The gene discussed is TP53; the disease is cancer.